Suppression of resistance to drugs targeted to human immunodeficiency virus reverse transcriptase by combination therapy.
about
Multidrug-resistance protein 5 is a multispecific organic anion transporter able to transport nucleotide analogsStructural basis for activation of α-boranophosphate nucleotide analogues targeting drug-resistant reverse transcriptaseThe polymerase L528M mutation cooperates with nucleotide binding-site mutations, increasing hepatitis B virus replication and drug resistanceThe valine-to-threonine 75 substitution in human immunodeficiency virus type 1 reverse transcriptase and its relation with stavudine resistance.Potentiation of inhibition of wild-type and mutant human immunodeficiency virus type 1 reverse transcriptases by combinations of nonnucleoside inhibitors and d- and L-(beta)-dideoxynucleoside triphosphate analogs.Resistance of hepatitis B virus to antiviral drugs: current aspects and directions for future investigation.The M184V mutation reduces the selective excision of zidovudine 5'-monophosphate (AZTMP) by the reverse transcriptase of human immunodeficiency virus type 1Involvement of novel human immunodeficiency virus type 1 reverse transcriptase mutations in the regulation of resistance to nucleoside inhibitorsThe phenylmethylthiazolylthiourea nonnucleoside reverse transcriptase (RT) inhibitor MSK-076 selects for a resistance mutation in the active site of human immunodeficiency virus type 2 RT.Inhibition of human immunodeficiency virus by a new class of pyridine oxide derivatives.Genetic and phenotypic analyses of human immunodeficiency virus type 1 escape from a small-molecule CCR5 inhibitor.In vitro characterization of a simian immunodeficiency virus-human immunodeficiency virus (HIV) chimera expressing HIV type 1 reverse transcriptase to study antiviral resistance in pigtail macaques.The Y181C substitution in 3'-azido-3'-deoxythymidine-resistant human immunodeficiency virus, type 1, reverse transcriptase suppresses the ATP-mediated repair of the 3'-azido-3'-deoxythymidine 5'-monophosphate-terminated primer.Role of a dipeptide insertion between codons 69 and 70 of HIV-1 reverse transcriptase in the mechanism of AZT resistance.HIV-1 resistance profile of the novel nucleoside reverse transcriptase inhibitor beta-D-2',3'-dideoxy-2',3'-didehydro-5-fluorocytidine (Reverset).Ethanol decreases the efficiency of phosphorylation of thymidine kinase in a human T-lymphocytic cell line.Mutations at the CXCR4 interaction sites for AMD3100 influence anti-CXCR4 antibody binding and HIV-1 entry.Mechanism-based suppression of dideoxynucleotide resistance by K65R human immunodeficiency virus reverse transcriptase using an alpha-boranophosphate nucleoside analogue.Homo and heterodimers of ddI, d4T and AZT: influence of (5'-5') thiolcabonate-carbamate linkage on anti-HIV activity.Current state-of-the-art in preclinical and clinical development of novel non-nucleoside HIV-1 reverse transcriptase inhibitors
P2860
Q24681283-9E898F12-CCFF-44D2-B199-33FEB3F45FCAQ27625384-A7AF331F-3F0B-4656-90C6-26D2096BE396Q28350136-701530C0-2816-450A-A653-0CD382EED8FAQ31779475-EC655F4E-B255-4359-B3E4-2AD50BA5A0BAQ33981912-8DA992BD-9646-4D90-B8F6-5E091E555EC2Q34299035-0FDDB574-2FB0-42B6-B3C0-6B842E45D9B6Q34334682-3D3D6012-AD6B-445A-BA75-0163A4AFF153Q34717615-B54F697F-13BF-4403-BB4B-9705C400DA81Q35123663-4DA4B3C8-2F22-446E-B169-B64909F62033Q35685039-02A64B64-9CF2-47B9-A6B1-28D76EA8966BQ36509765-29257A56-8C4A-4695-9BEA-405C763825F2Q37682768-4C2DF8D4-421E-454B-8C9E-899438BC8014Q38351813-14A6F6AA-E5EB-45EA-A826-ECC3CC85FDDAQ40388003-8E615CB6-C9EB-4414-8B2D-39051E4174E5Q40642031-EFB048B2-EA6D-470A-A0DD-4CF907C98242Q40741450-D9B1E324-80C0-4655-A922-131BB4BB5920Q44495038-1AC3CB77-4177-4F85-8990-712D9A1DF010Q44916253-0928BC90-165A-41D5-8839-91C499BA9A8FQ46705741-D5A12E9C-05BA-458C-9C66-BD04A2754D4EQ57266180-877728B5-1572-4596-9690-DFA47D9EFCF6
P2860
Suppression of resistance to drugs targeted to human immunodeficiency virus reverse transcriptase by combination therapy.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Suppression of resistance to d ...... iptase by combination therapy.
@ast
Suppression of resistance to d ...... iptase by combination therapy.
@en
type
label
Suppression of resistance to d ...... iptase by combination therapy.
@ast
Suppression of resistance to d ...... iptase by combination therapy.
@en
prefLabel
Suppression of resistance to d ...... iptase by combination therapy.
@ast
Suppression of resistance to d ...... iptase by combination therapy.
@en
P1476
Suppression of resistance to d ...... iptase by combination therapy.
@en
P2093
Balzarini J
P356
10.1016/S0006-2952(99)00029-5
P407
P577
1999-07-01T00:00:00Z